Home  > 
  Eisai seeks US FDA and EMA approval for anticancer agent lenvatinib to treat hepatocellular carcinoma,   July 27, 2017
  US FDA seeks more clinical data from Eli Lilly & Incyte's baricitinib NDA,   July 26, 2017
  GSK seeks US FDA approval for Arnuity Ellipta to treat asthma in children,   July 26, 2017
  US FDA accepts Bristol-Myers' sBLA for Opdivo four-week dosing schedule,   July 25, 2017
  Chugai files NDA with MHLW for bispecific monoclonal antibody emicizumab to treat haemophilia A with factor VIII inhibitors,   July 25, 2017
  Copley Scientific plans to expand its UK HQ to support growing international business,   July 25, 2017
  ISPE releases baseline guide “Risk-based manufacture of pharmaceutical products (second edition),   July 25, 2017
  Bristol-Myers' Yervoy gets US FDA expanded approval to include pediatric patients 12 yrs & older with unresectable or metastatic melanoma,   July 25, 2017
  US FDA accepts Amgen's BLA for Aimovig to treat migraine,   July 24, 2017
  GSK seeks EU nod for extended use of Relvar Ellipta in patients with controlled asthma on an ICS/LABA combination,   July 24, 2017
  EMA committee recommends approval of Merck's anti-PD-1 therapy, Keytruda for bladder cancer,   July 24, 2017
  GSK's self-injectable formulation of Benlysta to treat SLE receives US FDA approval,   July 24, 2017
  MAH symposium positive on Chinese pharma market prospects,   July 24, 2017
  US FDA accepts Evolus' BLA for DWP-450 to treat adult patients with glabellar lines,   July 21, 2017
  GSK to invest £140mn in next 3 years to support expansion of manufacturing for respiratory & HIV medicines,   July 21, 2017
  Humabs BioMed, University of California, Berkeley publicize data for novel antibody to detect Zika virus infection,   July 20, 2017
  Health Canada approves Cardiome Pharma's Aggrastat high dose bolus regimen,   July 20, 2017
  Zymeworks to receive one mn dollars bispecific antibody research milestone from Daaichi Sankyo,   July 20, 2017
  Gilead's Vosevi receives US FDA approval for re-treatment of adults with chronic hepatitis C virus,   July 20, 2017
  US FDA accepts Otonomy's Otiprio sNDA filing for acute otitis externa,   July 20, 2017

Copyright © 2016 Saffron Media Pvt. Ltd |